]>
IRCT20200120046203N1 IRCT 2020-03-12 Hamedan University of Medical Sciences Trajectories of change in depressive symptoms during group behavioral activation Assessment of the effectiveness of group behavioral activation on trajectories of change in depressive symptoms in patients diagnosed with major depressive disorder 2020-02-09 anticipated 60 Complete https://irct.ir/trial/45249 interventional Randomization: N/A, Blinding: Not blinded, Placebo: Not used, Assignment: Single, Purpose: Education/Guidance. N/A Condition 1: Major depressive disorder. Condition 2: Major depressive disorder. Intervention group: behavioral activation, in 10 weeks, in 7 to 10 participant groups, the sessions content is as follows: First session learning patterns (groups introduction, introducing the concept of behavioral activation, starting self-monitoring), second session start changing patterns (relating self-monitoring to avoidance, introducing functional analysis of avoidance), third session taking action (changing avoidance into action, setting plans), fourth session understanding challenges (to learn about barriers of change), fifth session rumination (understanding rumination as a barrier to become active, learning the difference between productive and unproductive thinking, analysis of what makes individual ruminate, identifying behaviors to replace rumination), sixth session mindfulness and being present in the moment (introducing techniques to help individual become engaged in routine activities), seventh session empathizing with self (identifying how individuals speak to themselves that lead to rumination, findings ways to change it to a compassionate voice), eighth session planning ahead ( review of previous sessions and individual gains, working on barriers on the way of introduced techniques, plan for the future), ninth session values (aid participants to cope with their life situations through mindful ways of living rather than focusing on the outcome), tenth session resilience (to review future application of learned strategies in times of emotional distress, plan for living a more enjoyable life, giving feedback on participation in group). Yes - There is a plan to make this available What will be shared: All acquired data can be shared after identifying information being omitted and it will be shared with the academic and research centers as well as the Ministry of Health and Education if necessary. When: Accessible in 6 months after publication of results To whom: Academic staff, health policy makers Conditions: For assessment of usability in similar studies, for planning to improve health outcomes at community level Where to obtain: Sara Sardashti, through email contact How to obtain: Assessment by the person in charge, confirmation by the principal investigator Comments:
public Latif Moradveisi
Farschian (Sina) Hospital, Mirzadeh Eshghi Avenue
Hamedan Iran (Islamic Republic of) 6516848741 +98 81 3827 4184 l.moradveisi@umsha.ac.ir Hamedan University of Medical Sciences scientific Sara Sardashti
Farschian Sina Hospital, Mirzadeh Eshghi Avenue
Hamedan Iran (Islamic Republic of) 6516848741 0098138274184 sarasardashti@gmail.com Hamedan University of Medical Sciences Iran (Islamic Republic of) Having the minimum age of 18 and maximum age of 65 Having the diagnosis of major depressive disorder based on clinical interview and Structured Clinical Interview for DSM 5 (SCID) Participants tendency to participate in group versus individual therapy Presence of moderate to severe depression based on Beck Depression Inventory II (BDI-II) Minimum education level of primary school (5 years) 18 years 65 years Both Presence or history of major neurological disorders (e.g. epilepsy, multiple sclerosis) Presence of prolonged interpersonal issues hindering participation in group Diagnosis of obsessive compulsive disorder Diagnosis of antisocial personality disorder Current or prior substance or alcohol use in the recent 12 months Prior history of hypomanic or manic episode Current or prior history of psychosis History of organic brain damage Simultaneous participation in other psychological therapies F32 F33 Major depressive disorder, single episode Major depressive disorder, recurrent Treatment - Other Intervention group: behavioral activation, in 10 weeks, in 7 to 10 participant groups, the sessions content is as follows: First session learning patterns (groups introduction, introducing the concept of behavioral activation, starting self-monitoring), second session start changing patterns (relating self-monitoring to avoidance, introducing functional analysis of avoidance), third session taking action (changing avoidance into action, setting plans), fourth session understanding challenges (to learn about barriers of change), fifth session rumination (understanding rumination as a barrier to become active, learning the difference between productive and unproductive thinking, analysis of what makes individual ruminate, identifying behaviors to replace rumination), sixth session mindfulness and being present in the moment (introducing techniques to help individual become engaged in routine activities), seventh session empathizing with self (identifying how individuals speak to themselves that lead to rumination, findings ways to change it to a compassionate voice), eighth session planning ahead ( review of previous sessions and individual gains, working on barriers on the way of introduced techniques, plan for the future), ninth session values (aid participants to cope with their life situations through mindful ways of living rather than focusing on the outcome), tenth session resilience (to review future application of learned strategies in times of emotional distress, plan for living a more enjoyable life, giving feedback on participation in group) Depression score in Beck Depression Inventory. Timepoint: Assessment of depression score at baseline, week 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, and 1 month after the last week. Method of measurement: Beck Depression Inventory. Hamedan University of Medical Sciences Approved 2019-09-15 Ethics committee of Hamedan University of Medical Sciences Farshchian Hospital, Mirzadeh Eshghi Street Hamedan Hamadan Iran (Islamic Republic of)